POPULATION HEALTH & DRUG SAFETY LAB
群體健康與藥物安全研究室 @ NDMC
AbOUT PHDS LAB
We are the Population Health & Drug Safety Lab, at National Defense Medical Center in Taiwan. Our work draws from clinical and health information in the real world. By using appropriate designs and statistical strategies, we carry out research in a variety of clinical areas including dermatology, psychiatry, and obstetrics & gynecology. Our goal is providing comprehensive viewpoints on population health and drug safety. Furthermore, we attempt to support meaningful health system change through real-world evidences.
PHDS LAB NEWS
[2024/07] 恭喜本研究室歐千華同學研究成果獲國際期刊 Journal of the American Academy of Dermatology 與Clinical and Experimental Dermatology 接受！
[2024/07] 恭喜本研究室江盈珊同學榮獲國科會大專學生參與專題研究計畫補助！
[2024/05] 恭喜本研究室楊惠雯、庹聖茵、聞遠亮、許嘉露、高銘駿同學專題成果入選 2024 ISPE's 40th International Conference on Pharmacoepidemiology (ICPE) Poster!
[2023/10] 恭喜本研究室歐千華同學、鄭淙瑋同學專題成果入選 2023 FAPA Congress Poster!
[2023/07] 恭喜本研究室江宜霖同學榮獲ISPE's 39th International Conference on Pharmacoepidemiology (ICPE) 2023 Scholarship 與獲選 ICPE 2023 Spotlight Poster！
[2023/07] 恭喜本研究室許嘉露同學、陳宗琦同學榮獲國科會大專學生參與專題研究計畫補助！
[2022/10] 恭喜本研究室江宜霖同學榮獲 ISPE's 14th Asian Conference on Pharmacoepidemiology (ACPE) Spotlight Poster Award (in-person)！
[2022/07] 張天又同學、王鴻展主任與本研究室合作之研究成果獲國際期刊 European Journal of Pharmaceutical Sciences 接受！
[2022/06] 恭喜本研究室歐千華同學、鄭淙瑋同學榮獲科技部大專學生參與專題研究計畫補助！
[2021/01] 本研究室鍾佩珣同學研究成果獲國際期刊 International Journal of Epidemiology 接受！
[2021/01] 本研究室曾雅梅博士研究成果獲國際期刊 Journal of Affective Disorders 接受！
[2020/11] 恭喜本研究室鍾佩珣同學榮獲 第二屆臺灣藥學聯合學術研討會 壁報論文競賽優秀論文獎！
[2020/09] 陳奕先醫師與本研究室合作之研究成果獲國際期刊 Journal of Affective Disorders 接受！
[2020/01] 本研究室研究成果獲國際期刊 Journal of the American Academy of Dermatology 接受！
RESEARCH FOCUS
DRUG SAFETY
Drug Safety Evaluation in Special Populations
Utilizing real-world data to assess drug safety, especially for pregnant women and children, and providing clinical evidence to clinicians
DERMATOLOGY
Inflammatory Skin Diseases
Investigating the health of people with inflammatory skin diseases and exploring potential risk factors using real-world data
PSYCHIATRY
Depressive Disorder
Evaluating drug safety, comorbidities, and healthcare utilization in patients with depressive disorder
CANCER
Immune Therapy
Assessing drug safety and effectiveness of immune checkpoint inhibitors and novel therapies
